Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer 2024-11-06 20:00
MEGAROBO Unveils High-Content Cell Imaging System for Advanced Multidimensional Biological Analysis 2024-11-06 19:00
Minghui Pharmaceutical Announces Promising Initial Results from Phase I Clinical Trial of MHB039A, a Novel PD-1 x VEGF Bispecific Antibody, in Patients with Relapsed/Refractory Solid Tumors 2024-11-06 18:00
QureBio Ltd. to Present its Q-1802 Clinical PhaseⅡ Data at 2024 SITC 39th Annual Meeting 2024-11-06 13:00
Duoning Biotech announced strategic partnership with Branca Bunús to promote the next generation of transfection reagents 2024-11-06 09:24
Complete Genomics Announces Spatial Omics Distributor Agreement, Debuts Spatial Xcellerator Grant Program at SITC 2024 2024-11-05 22:00
J INTS BIO Launches AI-Supercomputing Alliance to Transform Cancer Therapy 2024-11-05 17:38
BioCity presents late-breaking clinical trial results with SC0062 for IgA Nephropathy at ASN Kidney Week 2024 as published in the Journal of the American Society of Nephrology 2024-11-05 11:09
The clinical trial application for first-line treatment of extensive disease small cell lung cancer with Chiauranib has been approved 2024-11-01 19:04
HanAll Biopharma Reports Q3 2024 Financial Results and Provides Business Update 2024-11-01 19:00
Senhwa Biosciences Announces the Appointment of Dr. Yiu-Lian Fong, the Former Global Head of Janssen Diagnostic Innovation and R&D at Johnson & Johnson as the New Corporate Director 2024-11-01 15:28
PharmaResearch Hosts 5th Global Symposium on 'Rejuran' 2024-11-01 14:01
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combination as First-Line Therapy for Biliary Tract Tumors, Compared to Durvalumab 2024-11-01 11:34
CARsgen® U.S. Clinical Holds Lifted by FDA 2024-11-01 09:33
I-Mab to Release Q3 2024 Financial Results on November 14, 2024 2024-10-31 19:00
Cancer trial: retraining immune cells offers new hope for patients in personalized medicine breakthrough 2024-10-31 18:00
ZYMFENTRA® (infliximab-dyyb) coverage continues to increase through partnership with top 3 Pharmacy Benefit Managers (PBMs) 2024-10-31 14:31
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC 2024-10-31 12:02
MGI's DNBSEQ-T20 x2 Selected As A Special Mention In TIME Best Inventions 2024 2024-10-31 10:51
Abionic's CAPSULE PSP Receives FDA Approval for Early Detection of Sepsis; Fapon Introduces Exclusive PSP Solution in China via Licensing Collaboration 2024-10-31 10:26
1 5 6 7 8 9 226